New England Research & Management, Inc. Biogen Inc. Transaction History

New England Research & Management, Inc.

  • $204 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 08, 2020
SELL
$264.77 - $305.71 $364,058 - $420,351
-1,375 Closed
0 $0
Q2 2020

Jul 15, 2020
BUY
$258.66 - $342.55 $355,657 - $471,006
1,375 New
1,375 $368,000
Q1 2020

Jun 15, 2020
SELL
$268.85 - $341.04 $309,177 - $392,196
-1,150 Closed
0 $0
Q4 2019

Jan 14, 2020
BUY
$220.06 - $304.07 $253,069 - $349,680
1,150 New
1,150 $341,000

Others Institutions Holding BIIB

# of Institutions
1,047
Shares Held
126M
Call Options Held
1.37M
Put Options Held
1.35M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $32.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track New England Research & Management, Inc. Portfolio

Follow New England Research & Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on New England Research & Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email